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Gut microbiome–host metabolic interactions affect human health and can be modified by probiotic
and prebiotic supplementation. Here, we have assessed the effects of consumption of a combination
of probiotics (Lactobacillus paracasei or L. rhamnosus) and two galactosyl-oligosaccharide
prebiotics on the symbiotic microbiome–mammalian supersystem using integrative metabolic
profiling and modeling of multiple compartments in germ-free mice inoculated with a model of
human baby microbiota. We have shown specific impacts of two prebiotics on the microbial
populations of HBM mice when co-administered with two probiotics. We observed an increase in the
populations of Bifidobacterium longum and B. breve, and a reduction in Clostridium perfringens,
which were more marked when combining prebiotics with L. rhamnosus. In turn, these microbial
effects were associated with modulation of a range of host metabolic pathways observed via changes
in lipid profiles, gluconeogenesis, and amino-acid and methylamine metabolism associated to
fermentation of carbohydrates by different bacterial strains. These results provide evidence for the
potential use of prebiotics for beneficially modifying the gut microbial balance as well as host energy
and lipid homeostasis.
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Introduction
Adult humans carry ca. 1.5 kg of gut microbial symbiotic and
commensal organisms that are in intimate communication
with the host metabolic and immune systems (Nicholson et al,
2005; Dethlefsen et al, 2007). This symbiosis is the result of a
long period of co-evolution and co-adaptation between the
host genotype and the complex and variable microbiome (Gill
et al, 2006). Consequently, to be able to understand how the
changes in environmental conditions and lifestyle influence
human genetics and physiology, one needs to elucidate how
these factors determine the distribution, activities and evolu-
tion of gut microbes, and subsequently transgenomic meta-
bolic interactions (Xu et al, 2003; Backhed et al, 2005;
Nicholson et al, 2005; Tannock, 2005; Sonnenburg et al,
2006; Blaut and Clavel, 2007; Turnbaugh et al, 2007). Thus, the
gut microbiota can be regarded as an extra-genomic functional
unit providing extra control mechanisms that affect the host’s
nutritional status and health (Holmes and Nicholson, 2005;
Nicholson et al, 2005; Bik et al, 2006; Martin et al, 2006;
Eckburg and Relman, 2007). We have recently reported that
exogenous gut microbiome components can be transplanted
into a host and this results in modulation of the host calorific
bioavailability via differential metabolism of bile acids, and we
and others have surmised that related metabolic processes
might be involved in common metabolic diseases such as
obesity or type II diabetes (Dumas et al, 2006; Houten et al,
2006; Watanabe et al, 2006; Martin et al, 2007a).
The effects of consuming live microbial supplements
(probiotics) on the microbial ecology and on human health
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and nutritional status have been investigated extensively over
many years (Collins and Gibson, 1999; Rastall, 2005; Sonnen-
burg et al, 2006; Martin et al, 2007b). It has been reported
recently that probiotic consumption can lead to modification
of the resident microbiota resulting in modulation of bile acid
and lipid metabolism, and alter the recirculation and distribu-
tion of fat within the host organisms (Martin et al, 2008). Other
reports suggest that the microbiota could be a contributing
factor to obesity (Ley et al, 2006; Sonnenburg et al, 2006;
Turnbaugh et al, 2006) and can, in addition, regulate host
genes controlling lipid transport and deposition (Backhed et al,
2004).
As an alternative, the combined use of prebiotics and
probiotics may have beneficial effects on health maintenance
through modulating the microbial functional ecology (Collins
and Gibson, 1999; Schrezenmeir and de Vrese, 2001).
Prebiotics are non-digestible food ingredients, generally
oligosaccharides, that modify the balance of the intestinal
microbiota by stimulating the activity of beneficial bacteria,
such as lactobacilli and bifidobacteria (Gibson and Roberfroid,
1995; Collins and Gibson, 1999). There is now considerable
evidence that manipulation of the gut microbiota by prebiotics
can beneficially influence the health of the host (Gibson and
Roberfroid, 1995; Roberfroid, 1998; Delzenne and Kok, 2001;
Sartor, 2004; Lim et al, 2005; Rastall, 2005; Parracho et al,
2007). In particular, many attempts have been made to control
serum triacylglycerol concentrations through modification of
dietary habits with regard to consumption of pre- and
probiotics (Delzenne and Kok, 2001; Pereira and Gibson,
2002). Furthermore, unlike probiotics, prebiotics are not
subject to biological viability problems and thus can be
incorporated into a wide range of alimentary products (milk,
yogurts, biscuits) and they target organisms that are natural
residents of the gut microbiota (Gibson and Roberfroid, 1995).
For example, oligosaccharides have been suggested to
represent the most important prebiotic dietary factor in human
milk, promoting the development of a beneficial intestinal
microbiota (Kunz et al, 2000; Bode, 2006).
Nowadays, clinical trials support the claims of efficacy of
pro- and prebiotic nutritional intervention with regard to
various proposed beneficial health effects, and this has raised
the requirement for providing additional evidence and for
elucidation of the molecular bases of their action. This can be
captured effectively only by studying the global system
response of an organism to an intervention using top-down
systems biology approaches. Metabolic profiling using high-
resolution spectroscopic methods with subsequent multi-
variate statistical analyses is a well-established strategy for
differential metabolic pathway profiling (Nicholson et al,
2005; Griffin and Nicholls, 2006; Ellis et al, 2007). Noticeably,
the metabolic effects of various dietary modulations of gut
microbiota have been successfully characterized using this
approach (Wang et al, 2005, 2007; Martin et al, 2006; Stella
et al, 2006; Goodacre, 2007; Rezzi et al, 2007). Recently, we
have described that germ-free mice re-inoculated with a model
of human baby microbiota (HBM mice) offer a simplified
microbiome mouse model well adapted to assess the impact of
nutritional intervention on the gut microbial functional
ecosystem and subsequent effects on host metabolism (Martin
et al, 2008). Interestingly, the microbiota model shows a
number of similarities with the microbiota found in formula-
fed neonates (Mackie et al, 1999). However, we also reported
the limitations associated with gut colonization by a non-
adapted microbiota and the subsequent alterations of host and
microbial metabolism (Martin et al, 2007a).
The aim of the present study is to extend our previous
investigations evaluating metabolic response to probiotics in
HBM mice (Martin et al, 2008). In our previous study, we had
shown alterations in carbohydrate and protein fermentation
with subsequent effects on host lipid and energy metabolism,
which were more marked with Lactobacillus paracasei than
L. rhamnosus. In the current study, we compare the effects of
consumption of a synthetic galactosyl-oligosaccharide (Pre1)
with those due to consumption of an in-house preparation of
galactosyl-oligosaccharides (Pre2). We have assessed the
impact of prebiotics on the microbial balance and the
mammalian metabolism of HBM mice supplemented with a
probiotic, L. paracasei or L. rhamnosus (Figure 1). Here, we
show a significant association of specific metabotypes
obtained from urine, plasma, fecal extracts and intact liver
tissue with changes of the gut microbiome induced by the
prebiotic supplementation.
Results
Effects of pre- and probiotics on microbial
composition and animal weight
The effects of prebiotics on the populations of microbiota in
the jejunum and the feces are summarized in Table I. Fecal
microbiota for the control groups (HBM alone, HBMþ L.
paracasei and HBMþ L. rhamnosus) have previously been
published (Martin et al, 2008). In the current and previous
studies (Martin et al, 2008), the impact of probiotics with and
without prebiotics on gut microbiota was assessed in the upper
gut and the feces. The effects of probiotics are indeed expected
along the whole gastrointestinal tract due to the great
adaptability of lactobacilli to extreme aerobic/anaerobic
conditions and low pH conditions (Tannock, 2004). However,
most prebiotics are complex carbohydrates that escape
digestion in the upper gastrointestinal tract and these are
fermented by certain bacteria in the colon (Gibson and
Roberfroid, 1995; Collins and Gibson, 1999). Nevertheless,
the ability of galactosyl-oligosaccharides to modulate the
upper gut microflora remains unclear and was thus also
investigated. Our results provide evidence that the populations
of microbiota in the fecal and jejunal content were modulated
by prebiotic supplementation. In general, prebiotic supple-
mentation slightly reduced the L. paracasei populations in
both the fecal and jejunal content and increased fecal
populations of Bifidobacterium breve and B. longum. Interest-
ingly, supplementation with Pre2 was correlated with lower
fecal populations of Clostridium perfringens in mice regardless
of which probiotics they receive. The jejunal population of
Bacteroides distasonis was decreased in HBM mice simulta-
neously supplemented with L. paracasei, whereas the number
of fecal Escherichia coli was reduced in HBM mice simulta-
neously colonized with L. rhamnosus.
A three-component projection to latent structure discrimi-
nant analysis (PLS-DA) model of mean-centered microbial
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counts in fecal and jejunal contents showed that the HBM
control mice samples formed a distinct cluster (Figure 2A,
black squares). Two subclusters of samples representing each
of the probiotics administered either alone or in combination
with prebiotics were observed in the plane described by Tcv1
and Tcv2 (red circles). These groups indicated that each
probiotic exerted a systematic and unique effect on the
microbiota as described previously (Martin et al, 2008). For
clarity, two-dimensional representations of the data scores
plots are given in Figure 2B and C along with the correspond-
ing loadings plots (Figure 2D and E). Interestingly, the
combination of L. rhamnosus and Pre2 formed a subcluster
along the first component Tcv1 closer to the control HBM
colonized group than the other nutritional intervention
groups, and this was predominantly influenced by higher
fecal B. longum and lower C. perfringens populations when
compared with other groups. The effects of the two prebiotics
(green triangles for Pre1 and blue diamonds for Pre2)
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L. paracasei 
28 HBM +
L. rhamnosus 
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Group E (n=10) 
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Figure 1 Schematic diagram of the experimental study design.
Table I Microbial species counts in mouse fecal and jejunal contents
Groups/log10 CFU HBM
(n=10)
HBM+
L. paracasei
(n=9)
HBM+
L. paracasei
+Pre1
(n=9)
HBM+
L. paracasei+
Pre2 (n=9)
HBM+
L. rhamnosus
(n=9)
HBM+
L. rhamnosus
+Pre1
(n=10)
HBM+
L. rhamnosus
+Pre2
(n=9)
Feses
L. paracasei — 8.5±0.2 8.3±0.3* 8.1±0.4** — — —
L. rhamnosus — — — — 7.8±0.2 7.6±0.4 7.9±0.3
E. coli 9.2±0.3 9.4±0.3 9.7±0.3 9.3±0.2 9.8±0.5 9.3±0.2* 9.3±0.2*
B. breve 9.1±0.2 7.78±2.13 8.5±1.5 8.7±1.5 8.7±0.3 9.8±0.3** 10.0±0.4***
B. longum 8.2±0.6 5.6±1.9 6.2±1.6 6.7±1.8 6.3±0.5 7.7±1.2** 9.3±1.04***
S. aureus 7.4±0.3 6.3±0.3 6.3±0.5 6.1±0.7 6.6±0.5 6.1±0.4 6.4±0.9
S. epidermidis 4.8±0.4 4.9±1.2 4.5±0.9 3.8±0.4 4.0±0.5 3.7±0.7 6.0±1.5
C. perfringens 7.2±0.3 7.0±0.5 6.5±1.0 5.9±0.6** 5.7±1.0 6.6±1.1 o5.0
Bacteroides distasonis 10.3±0.2 10.4±0.2 10.1±0.6 10.1±0.4 10.1±0.4 10.2±0.3 10.3±0.3
Jejunum
L. paracasei — 4.2±1.8 2.9±0.8 2.6±0.9* — — —
L. rhamnosus — — — — 3.6±1.3 3.1±1.3 3.0±0.8
E. coli 3.3±1.3 5.1±1.9 4.0±0.8 3.7±1.2 5.2±1.9 4.2±1.3 4.4±0.8
B. breve 2.7±1.4 2.5±1.0 2.7±1.3 3.0±1.4 2.4±0.8 4.0±1.6** 4.0±0.9**
B. longum o2.0 o2.0 o2.0 o2.0 o2.0 o2.0 o2.0
S. aureus 4.1±0.9 3.8±1.3 4.1±0.9 3.7±0.7 4.2±0.7 3.0±1.3* 4.0±0.5
S. epidermidis o3.0 o3.0 o3.0 o3.0 o3.0 o3.0 o3.0
C. perfringens 3.4±1.1 4.5±1.2 3.4±0.7 2.9±1.1 4.7±1.3 3.4±1.0* 3.2±0.5*
Bacteroides distasonis 3.4±1.6 4.8±1.6 3.2±1.2* 3.3±0.9* 3.8±1.7 4.0±1.3 4.1±1.3
Key: Log10 CFU (colony forming unit) given per gram of wet weight of feces or wet weight of jejunal content. Data are presented as mean±s.d. The average values
obtained from the HBM+probiotics mice supplemented with prebiotics were compared with corresponding HBM+probiotics control mice, *, ** and *** designate
significant difference at 95, 99 and 99.9% confidence level, respectively; —, probiotics not present in the gut microbiota.
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superimposed on the probiotic background were further
differentiated along component Tcv3. Multivariate data
analysis highlighted that prebiotic intervention was correlated
with increased B. longum and B. breve, and lower numbers of
E. coli and C. perfringens.
No effect of prebiotic supplementation on animal body
weight was observed (Supplementary Table 1).
Quantification of short-chain fatty acids
in the cecum
Several short-chain fatty acids (SCFAs), namely acetate,
propionate, isobutyrate, n-butyrate and isovalerate, were
identified and quantified from the cecal content using gas
chromatography (GC) with flame ionization detection. The
results, presented in Table II, are given in mmol per gram of dry
cecal material and as mean±s.d. for each group of mice. The
data for the control groups (HBM colonized mice without
further intervention and HBM colonized mice after adminis-
tration of a probiotic) have previously been published, but are
included here for comparative purposes (Martin et al, 2008).
The effect of prebiotic treatment on the production of SCFAs
was limited to a reduction in the production of propionate and
butyrate in HBM mice receiving L. rhamnosus combined with
Pre2 and a reduction in isobutyrate in HBM mice receiving
L. paracasei combined with Pre2 (Table II). Although cecal
L- and D-lactate were not actually measured in the present
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Figure 2 PLS-DA scores plots (A–C) and loading plots for the three predictive components (D, E) derived from PLS-DA model of log10 CFU (colony forming unit) for
the different bacterial species measured for fecal and jejunal samples from HBM control (black square), HBMþ L. rhamnosus (red dot), HBMþ L. rhamnosusþ Pre1
(blue diamond), HBMþ L. rhamnosusþ Pre2 (green triangle), HBMþ L. rhamnosus (red circle), HBMþ L. rhamnosusþ Pre1 (purple open diamond) and HBMþ
L. rhamnosusþ Pre2 (green open triangle). Loadings represent the bacterial populations, beginning with J or F for jejunal or fecal counts, respectively. The model
has been calculated with four predictive components and mean-centered data, RX
2¼76.5%, QY2¼51.3%. Key: B.a., Bacteroides distasonis; B.b., Bifidobacterium breve;
B.l., Bifidobacterium longum; C.p., Clostridium perfringens; E.c., Escherichia coli; L.p., Lactobacillus paracasei; L.r., Lactobacillus rhamnosus; S.a., Staphylococcus
aureus; S.e., Staphylococcus epidermidis.
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study, only minor changes in lactate were observed in similar
experiments with a slight reduction in cecal lactate when
feeding L. rhamnosusþ Pre2 (unpublished data).
1H NMR metabolic profiles of plasma, liver, fecal
extracts and urine
A comprehensive 1H nuclear magnetic resonance (NMR)
spectral comparison was carried out using orthogonal projec-
tion to latent structure discriminant analysis (O-PLS-DA) to
characterize metabolic changes associated with prebiotic
supplementation and the metabolic changes were verified by
two-dimensional NMR experiments as shown in Figure 3.
Several amino acids, glucosides and SCFAs were readily
assigned, as exemplified in Table III. Some 1H-1H cross-peaks
at d5.42:3.98, 5.52:3.79, 5.40:3.61 and 5.40:3.80 show values
typical of short-chain oligosaccharides, which are as yet
unidentified (Figure 3).
Goodness of fit (RX
2) and predictability (QY
2) values for
O-PLS-DA models calculated separately for NMR spectroscopic
data for plasma, urine, fecal extracts and intact liver tissues are
presented in Table III. All the models were calculated using one
predictive component and two orthogonal components using
the NMR data as the X matrix and the type of prebiotics
treatment (none, Pre1 or Pre2) as a dummy Y variable. No
impact of prebiotic supplementation on the metabolic profiles
of plasma was observed as indicated by the negative values of
QY
2 (Table III). However, prebiotic supplementation showed
significant effects on murine metabolic profiles of urine, fecal
extracts and liver, as reflected by the high values of QY
2 for
each model (Table III). The O-PLS-DA coefficients plots
for models based on NMR spectra of fecal extracts, liver tissue
and urine are presented in Figures 4 and Supplementary
Figures 1 and 2 together with metabolites with the highest
coefficient values responsible for the discriminatory variation
listed as mean±s.d. in Table III.
Fecal metabolic profiles
Pre1 and Pre2 caused marked effects on the metabolic profiles
of fecal extracts of mice colonized with HBM and L. paracasei,
and these effects included a marked increase in the concentra-
tions of some as yet unassigned oligosaccharide resonances
(O1, O3), which were associated with decreased levels of
resonances derived from other oligosaccharides (O2) for
Pre2 (Table III and Supplementary Figure 1). In HBM mice
supplemented with L. rhamnosus, Pre1 and Pre2 induced
some degree of reduction in the levels of unassigned
oligosaccharides (O2). Pre2 treatment was also correlated
with increases in the other unassigned oligosaccharides (O1
and O3).
Further O-PLS-DA models of a pairwise comparison
between Pre1 and Pre2 showed clear differences in the content
of oligosaccharides O1 and O3 between the groups of HBM
mice supplemented with either L. paracasei or L. rhamnosus
(Supplementary Figure 3A and B). The changes in the fecal
content of oligosaccharides O1 and O3 may thus result from
differences in the content of products obtained from the
digestion of prebiotics by the gut microbiota.Ta
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In HBM mice supplemented with L. paracasei, unique
effects of Pre1 included elevated levels of arginine and
citrulline, and reduced octanoic acid (caprylate) in the fecal
composition, whereas unique features of Pre2 ingestion
included a decrease in the levels of glucose, lysine, butyrate,
isovalerate and propionate. When combined with L. paracasei
supplementation, both prebiotic treatments were associated
with a reduction in the content of lactose. In addition, in the
feces of HBM mice supplemented with L. rhamnosus, Pre1
induced higher levels of arginine and citrulline, whereas Pre2
caused a decrease in lysine, butyrate and isovalerate. In HBM
mice supplemented with L. rhamnosus, both prebiotic treat-
ments were associated with a reduction in the content of
lactose, glucose, glutamate and octanoate.
Liver metabolite profiles
The liver of mice colonized with L. paracasei and receiving
either of the prebiotics was metabolically differentiated from
those fed with probiotics alone, as indicated by the increased
levels of glycogen, trimethylamine (TMA), polyunsaturated
fatty acids (PUFAs) and a range of amino acids (i.e. leucine,
isoleucine, glutamine, glutamate, glycine) and a decreased
concentration of triglycerides (Supplementary Figure 2A and B
and Table III). Moreover, Pre2 induced specific increases in the
levels of trimethylamine-N-oxide (TMAO) in L. paracasei
colonized animals.
In addition, L. rhamnosus colonized HBM mice supplemen-
ted with Pre1 were characterized by increased levels of amino
acids and PUFAs. Supplementation with Pre2 was specifically
associated with a reduction in the level of glycogen and an
increase in TMAO and phosphatidylcholine.
Urinary metabolite profiles
Prebiotic administration also affected the urinary metabolic
profiles of mice colonized with L. paracasei. These changes
were mainly manifested in decreased concentrations of a
putative mixture of lipids (unidentified lipids (ULp), chemical
shifts: 0.89(m), 1.27(m), 1.56(m), 2.25(m)) and an increase in
1-methylnicotinamide in mice fed with Pre1 or Pre2. In
addition, consumption of prebiotics was correlated with
higher levels of an unknown compound U1 (1H NMR chemical
shifts: 3.80(m), 4.30(t) as given by statistical total correlation
spectroscopy (STOCSY) analysis; Cloarec et al, 2005a) in urine.
Pre1 also caused decreased concentrations of phenylacetyl-
glycine, N-acetyl- and O-acetyl-glycoproteins, and tryptamine
and increased levels of citrate. Animals supplemented with
Pre2 showed elevation in the levels of glycerate, creatine and
TMA, which was associated with a reduction of a-keto-
isovalerate, arginine and citrulline. In addition, consumption
of Pre2 was correlated with higher levels of U1 and another
unknown compound U2 (1H NMR chemical shift: 4.21(s)).
In contrast, L. rhamnosus colonized mice treated with both
prebiotics showed higher urinary excretion of creatine, taurine
and U1, and a reduction in urinary levels of arginine and
citrulline. Feeding HBM mice with L. rhamnosus and Pre2 led
to increased urinary concentrations of ULp, TMA and U2, and
decreased levels of a-keto-isovalerate and creatinine.
Correlation analysis of inter-compartment
metabolite functional relationships
As the major changes following intervention with combined
use of pre- and probiotics occurred in the fecal and liver
matrices, a correlation analysis was conducted to identify any
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latent metabolic links between these two biological compart-
ments (Figure 5). Such analyses have been carried out on
groups of animals that received the same probiotic combined
with prebiotics or not. Pixel maps obtained from the two
groups of animals showed different intra- and inter-compart-
ment correlation patterns, which highlighted the metabolic
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differences previously described. In HBM mice receiving
L. paracasei supplementation, hepatic PUFAs and isoleucine
showed positive associations with the oligosaccharide
resonances O1 and O3, whereas hepatic triglycerides were
negatively correlated to O1 and O3. These data suggested a
direct relationship between carbohydrate digestion and liver
lipid metabolism. These metabolic links were not observed in
the matrix of correlations obtained from HBMþ L. rhamnosus.
Interestingly, negative correlations between O1 and O3 with
fecal SCFAs illustrate bacterial fermentation of dietary
carbohydrates in both groups. The pixel map also highlighted
the positive correlations between glucogenic amino acids,
glycogen and PUFAs in the liver, suggesting functional
relationships between glucogenesis and gluconeogenesis.
Correlation analysis of microbiotal variation
and SCFAs
A correlation analysis was applied to investigate the connec-
tions between levels of fecal and jejunal microbiota and the
cecal SCFAs using bipartite graphical modeling (Figure 6).
Positive and negative correlations between nodes show the
multicolinearity between SCFAs and gut bacteria, whose
concentrations are interdependent such as in the case of
substrate–product biochemical reactions. Correlation analysis
derived from SCFAs and fecal/jejunal microbiota profiles
offered a unique approach to describe intra-group sources of
variability and subtle alterations in SCFAs in relation to gut
bacterial changes. By comparing the networks obtained with
different treatments, we can highlight significant differential
patterns, suggesting different functional ecology in relation to
different microbial populations and activities. HBM mice
supplemented with different probiotic/prebiotic combinations
show remarkably different SCFA/microbial correlation
networks (Figure 6), indicating that probiotic and prebiotic
modulation of the microbiome can result in specific functional
ecological changes. In particular, we observed that microbial
changes in the upper gut and fecal pellet showed a functional
relationship with the intestinal content of SCFAs. Such data
can help to generate testable hypotheses on differential
bacterial metabolism in response to a stressor.
In particular, network analysis for HBM mice supplemented
with L. paracasei revealed that dietary oligosaccharide
supplementation induced significant changes in the functional
linkage between the acetate and propionate levels,
and lactobacilli, bifidobacteria, Bacteroides distasonis and
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Figure 5 Integration of inter-compartment metabolic correlations. The pixel maps were derived from correlations between liver and fecal metabolites found to be
significantly different with nutritional intervention in each group of mice colonized with one type of probiotic. The intra- and inter-compartmental metabolite correlations
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C. perfringens. Interestingly, fecal bacterial changes showed
strong correlations with the cecal composition of SCFAs in
mice not supplemented with prebiotics (Figure 6A). Animals
receiving prebiotics showed a greater number of statistically
significant correlations between the jejunal microbiota
changes and the SCFAs. Moreover, Pre1 induced negative
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Figure 6 Integration of SCFAs and microbiota correlations. The bipartite graphs were derived from correlations between microbiota (fecal and jejunal) and SCFAs in
each of the six groups of mice. HBM mice were supplemented with L. paracasei without prebiotics (A), with Pre1 (B) and with Pre2 (C), and HBM mice were
supplemented with L. rhamnosus (D), with Pre1 (E) and with Pre2 (F). The cutoff value of 0.5 was applied to the absolute value of the coefficient |r| for displaying the
correlations between microbiota and SCFAs. SCFAs, and intestinal and fecal bacteria correspond to yellow ellipse nodes, and blue and green rectangle nodes,
respectively. Edges are coded according to correlation value: positive and negative correlations are displayed in blue and red, respectively. Key: Ba., Bacteroides
distasonis; Bb., Bifidobacterium breve; Bl, Bifidobacterium longum; C2, acetate; C3, propionate; C4, butyrate; iC4, isobutyrate; C5, valerate; iC5, isovalerate; Cp,
Clostridium perfringens; Ec, Escherichia coli; La, Lactobacilli probiotics; Sa, Staphylococcus aureus; Se, Staphylococcus epidermidis. Bacterial names starting with
‘F_’ and ‘I_’ correspond to fecal and intestinal bacteria, respectively.
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and positive correlations between SCFAs and C. perfringens
and B. breve, respectively (Figure 6B). Pre2 supplementation
was associated with positive correlations between SCFAs
(acetate and propionate) and both Bacteroides distasonis and
B. breve (Figure 6C). In contrast, negative correlations were
observed for S. aureus with most of the SCFAs (Figure 6C).
When HBM mice received L. rhamnosus with or without
prebiotics, the microbiome/SCFAs network showed a simpler
structure. Such observations suggest different bacterial inter-
actions in both HBMþ probiotic models. Available microbial
data support this idea as seen, for instance, with the specific
inhibition of B. breve growth with L. paracasei but not with
L. rhamnosus. In contrast with animals supplemented with
L. paracasei alone, variation in the intestinal bacterial
populations from mice that received L. rhamnosus was
strongly correlated with the cecal composition in SCFAs
(Figure 6D). Moreover, Pre1 induced correlations between
the cecal content in acetate and the balance between B. breve,
B. longum and C. perfringens. Interestingly, Pre2 appeared to
initiate functional relationships between the main SCFAs
(acetate, propionate and butyrate) and Bacteroides distasonis,
C. perfringens and lactobacilli.
Discussion
We have shown specific effects of two prebiotics on the
microbial populations of HBM mice when co-administered with
two probiotics. These microbial changes were associated
with specific host metabolic phenotypes, for example, variations
in the fecal carbohydrate content, reduction in the levels of
hepatic triglyceride content and increased hepatic concentrations
of PUFAs and hepatic glucogenic amino acids. These data provide
further evidence for the critical involvement of prebiotics in host
metabolism through modulation of the gut microbiome.
Effects of prebiotics on gut functional ecology
Previous work on humans has described the fragile equili-
brium between the host and beneficial gut bacteria (lactoba-
cilli, bifidobacteria) and potentially detrimental species
(Clostridium spp, Staphylococcus spp and the members of the
Enterobacteria and Bacteroides groups), and this ultimately
determines the health and nutritional status of the host
(Collins and Gibson, 1999; Pereira and Gibson, 2002; Gopal
et al, 2003; Martin et al, 2006; Sonnenburg et al, 2006). Our
data provide additional evidence that the populations of
beneficial bacteria in the gastrointestinal tract can, to some
extent, be controlled with dietary interventions, here based on
supplementation with galactosyl-oligosaccharides. Here, in-
creases in the fecal populations of beneficial bacteria, namely
B. longum and B. breve (Table I), were specifically associated
with supplementation of prebiotics, Pre2 offering a greater
ability to modulate the gut microbiota in HBM mice compared
with Pre1. Galacto-oligosaccharides are the preferred growth
substrates for bifidobacteria and lactobacilli that have an
extraordinary ability to acquire and degrade oligosaccharides
(Kikuchi et al, 1992; Ito et al, 1993; Rycroft et al, 2001; Tzortzis
et al, 2005; Macfarlane et al, 2006). Pure bacterial cultures
indicated that L. rhamnosus and L. paracasei were not able to
grow on culture media containing Pre1, whereas B. breve and
B. longum did not show any difference in growth when
cultured on Pre1, glucose or lactose media (unpublished data).
In addition, the ability of B. longum (Hopkins et al, 1998;
Macfarlane et al, 2008) and B. breve (Djouzi et al, 1995) to
utilize extensively galacto-oligosaccharides for growth was
previously reported in vivo, whereas only a few Lactobacillus
species could use this substrate efficiently, unlike L. rhamno-
sus (Gopal et al, 2001). This bacterial capacity is strongly
dependent on the pattern of glycosidic linkages present in the
galacto-oligosaccharides and thus on the existence of specific
b-galactosidases, as evidenced for B. longum by genome
analysis (Schell et al, 2002).
It has been previously reported that bacterial fermentation
of carbohydrate may result in inhibition of the growth of
pathogens by acidification of the environment through the
production of large quantities of carboxylic acids (Kikuchi
et al, 1992; Ito et al, 1993; Rowland, 1993; Gibson and
Roberfroid, 1995; Djouzi and Andrieux, 1997). In the current
study, prebiotic supplementation resulted in a reduction in
E. coli and C. perfringens bacterial counts in the feces (Table I),
which is in agreement with previous reports (Rycroft et al,
2001; Tzortzis et al, 2005). Our results suggest that the
association of Pre2 with L. rhamnosus enables a more
significant reduction in pathogenic C. perfringens and an
increase in health-promoting B. longum populations in feces
and jejunal content. However, measures of cecal SCFAs did not
reveal significant alterations in total concentrations and
composition with prebiotic treatment (Table II), whereas
changes were more marked in the stool (Table III). Therefore,
it remains unclear if the gut microbial changes result directly
from the fermentation of galactosyl-oligosaccharides and
acidification of the luminal environment. Moreover, the
significant increase in fecal bifidobacteria suggests that a
different bacterial fermentation may occur in the colon, and
measures of cecal pH and of colonic content of SCFAs will help
in the interpretation in future studies.
However, our results show that the type of prebiotic (Pre1 or
Pre2) entering the large intestine has differential effects on
bacterial metabolism and is in agreement with the different
abilities of bacteria such as lactobacilli, bifidobacteria and
Bacteroides spp to hydrolyze carbohydrates, as reported
previously (Hidaka and Hirayama, 1991; Djouzi and Andrieux,
1997). Application of network analysis to display the relation-
ships between cecal SCFAs and microbial profiles revealed
different intra-group patterns (Figure 6). These observations
suggest that prebiotics induced a specific functional ecology in
relation to different microbial populations and activities.
For instance, the negative correlations between SCFAs and
C. perfringens and E. coli, and positive correlations between
SCFAs and bifidobacteria, lactobacilli and Bacteroides distasonis
consistently indicate a link between SCFA production and certain
changes in bacterial populations, such as reduction in pathogens.
Moreover, C. perfringens being a primary butyrate producer, the
specific anti-correlation with butyrate may also indicate that in
response to stressors, C. perfringens activities may be shifted and
stimulated. In particular, measures of bacterial activities
in similar mouse models showed that the reduction of
C. perfringens counts was associated with an increased activity
in response to Pre2 supplementation (unpublished data).
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In HBM mice supplemented with L. paracasei, populations
of lactobacilli were slightly reduced with both prebiotic
supplementations, and bifidobacteria showed only upward
trends, which suggested a competition for the prebiotics
between bifidobacteria and L. paracasei. Moreover, the
observation of higher fecal content of oligosaccharides O1
and O3 specific to HBM mice fed with prebiotics and
L. paracasei indicated that the microbiota may use these
substrates poorly when compared with groups with
L. rhamnosus. This information suggests a higher efficiency
of bacterial hydrolysis and intestinal absorption of dietary
oligosaccharides in animals fed with prebiotics and
L. rhamnosus (Table III and Supplementary Figures 1 and 3).
Furthermore, ingestion of galacto-oligosaccharides or fruc-
to-oligosaccharides is known to specifically induce bacterial
hydrolysis of the substrate (Djouzi and Andrieux, 1997), as
well as to modulate some bacterial activities, including
glycolytic properties, hydrolysis of oligosaccharides and
glucuronides, reduction of nitro-compounds, and formation
of phenols and indoles (Mitsuoka et al, 1987; Ito et al, 1993;
Rowland, 1993). In the current study, decreased levels of lysine
in feces (Table III), isobutyrate in cecum (Table II) and
N-acetyl-glycoproteins in the urine (Table III) suggest that
prebiotic treatment decreased overall bacterial proteolysis in
animals also receiving L. paracasei (Macfarlane et al, 1992;
Hallson et al, 1997; Metges, 2000). Investigation of the
metabolite changes in urinary excretion showed a significant
decrease in the concentrations of microbial co-metabolites
PAG and tryptamine (Goodwin et al, 1994; Smith and
Macfarlane, 1996), which also supports decreased bacterial
proteolytic activities. Altogether, our data suggest that
prebiotics intervention may reduce proteolytic activities
previously ascribed to the basal metabolism of L. paracasei
on casein medium (Martin et al, 2008), which is in agreement
with the reduced number of these bacteria observed in
this study.
In addition, methylamines, as a class of compounds, are
another well-documented example of metabolites derived
from host–microbial interactions produced within the large
intestine (Smith et al, 1994). A significant fraction of ingested
choline is converted by microbial enzymes to TMA (Zeisel
et al, 1983), which is either oxidized to TMAO in the liver or
excreted into the urine (Smith et al, 1994). Increases in the
levels of TMA and TMAO in the liver and TMA in the urine
indicate that changes in methylamine metabolism were
induced by prebiotics, the changes being more marked with
Pre2 supplementation (Table III).
Impact of prebiotics on host energy and lipid
homeostasis
In parallel to gut microbial changes, relative reduction of
hepatic triglycerides and increased concentrations of PUFAs
were observed in mice supplemented with prebiotics. Non-
digestible but fermentable carbohydrates were reported to
decrease triglycerides in both serum and liver via modulation
of the activity and gene expression of the lipogenic enzymes
(Delzenne and Kok, 1998, 2001; Roberfroid and Delzenne,
1998; Pereira and Gibson, 2002). For instance, fatty acid
synthase is sensitive to nutrients and hormones (Girard et al,
1997), whereas insulin and glucose are essential factors
regulating fatty acid and triglyceride synthesis (Katsurada
et al, 1990; Girard et al, 1997). Moreover, fructan-type
prebiotic feeding may reduce the ability of isolated hepatocytes
to synthesize and secrete triglycerides by 54% (Kok et al,
1996), as well as their ability to esterify fatty acids into
triacylglycerols (Fiordaliso et al, 1995). A similar mechanism
might exist with galactosyl-oligosaccharides, which may
explain the relative increase in the NMR signals of PUFA-
containing phospholipids in the current study. PUFAs can act
by directing fatty acids away from triglyceride storage and
toward oxidation, and can also enhance glucose flux to
glycogen (Kliewer et al, 1997). These processes are supported
by the higher content of hepatic glutamine and branched-chain
amino acids observed here, which would have a lower
contribution to the citric acid cycle. No significant effects of
prebiotics on the plasma metabolic profiles were observed here
(Table III). Previously, we described that single probiotic
supplementation reduced the levels of plasma lipoproteins in
HBM mice by modulating the absorption of the dietary long-
chain PUFAs (Martin et al, 2008). Here, we report that similar
blood plasma metabolic profiles, associated with reduction of the
triglyceride content in the liver, can be obtained when combining
the probiotic with prebiotic supplements (Table III).
Notably, animals fed with L. paracasei in combination with
prebiotics showed the most significant hepatic reduction in
triglycerides, which was associated with a high fecal content of
oligosaccharides. Previous studies showed that some prebio-
tics induce changes in lipogenic enzyme activities by reducing
postprandial insulinemia and glycemia (Kok et al, 1998;
Delzenne and Kok, 2001) through stimulation of the intestinal
release of hormonal mediators (Morgan, 1996), or through
modification of the intestinal absorption of carbohydrates
(Stanley and Newsholme, 1985) and shortening small intest-
inal transit time (Roberfroid and Delzenne, 1998). Our results
suggest that a similar mechanism may be involved in mice
supplemented with prebiotics co-administered with L. para-
casei, as the higher concentrations of fecal oligosaccharides
may reflect poorer digestion and absorption resulting in lower
energy generation from carbohydrates, with a consequent
switch to fat metabolism. However, further work is needed to
understand the functional link between the residual fecal
carbohydrate and the digestion of prebiotics by the gut
microbiota, for instance by assessing experimentally the
metabolic abilities of the bacterial species to utilize the
prebiotics. Moreover, recent studies showed that the microbial
processing of dietary oligosaccharides modifies monosaccha-
ride uptake from the gut by regulating the activity of host
monosaccharide transporters, which can result in various
changes in hepatic metabolism, including modulation of
synthesis and deposition of triglycerides in adipocytes and
increased glycogenesis (Backhed et al, 2004). Here, prebiotic
supplementation was associated with relatively increased
levels of glutamate, glutamine, branched-chain amino
acids and alanine in the liver, as well as hepatic glycogen
accumulation when mice were specifically fed with
L. paracasei, which suggests stimulated gluconeogenesis and
glycogenesis (Table III).
The animals that received L. rhamnosus in combination
with either prebiotics showed elevated levels of urinary
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taurine and creatine, which is likely to be related to higher
muscular activity due to supplementation of the feed with new
sources of carbohydrates (Cuisinier et al, 2001). Moreover, it
has been shown that adipocyte-derived hormones, whose
expression correlates with adipocyte lipid content, can
increase energy expenditure in mice (Backhed et al, 2004).
These changes suggest that HBM supplemented with
L. rhamnosus supplies the host metabolism with new sources
of carbohydrates more efficiently, which leads to changes in
energy expenditure.
In conclusion, integrative systemic metabolic and micro-
biome profiling demonstrated the importance of nutritional
intervention based on prebiotics and probiotic combinations
in determining the host metabolic status and the levels of a
diverse range of compounds in multiple pathways. Our data
highlight that prebiotic nutritional intervention is a key factor
in determining the resulting host metabolic phenotypes. The
perspective of inducing unique changes in the host metabo-
lism triggered by unique combinations of prebiotics and
probiotics establishes an important step forward in the efforts
to develop tailored nutritional solutions at an individual level.
Materials and methods
Animal handling procedure and supplementation
of probiotics and prebiotics
All animal studies were carried out under appropriate national
guidelines at the Nestle´ Research Center (Lausanne, Switzerland).
The model of HBM consists of seven bacterial strains that were
isolated, using a previously described method (Guigoz et al, 2002),
from the stool of a 20-day-old female baby who was given birth by
normal delivery and breast-fed. A total of seven bacterial species were
isolated, namely E. coli, B. breve and B. longum, Staphylococcus
epidermidis and S. aureus, C. perfringens and Bacteroides distasonis,
and they were mixed in equal amounts (approximately 1010 cells/ml
for each strain) for gavage. Bacterial cell mixtures were kept in frozen
aliquots until use. L. paracasei NCC2461 and L. rhamnosus NCC4007
probiotics were obtained from the Nestle´ Culture Collection
(Lausanne, Switzerland).
A total of 65 C3H female germ-free mice, aged 6 weeks, received a
single dose of HBM bacterial mixture and were fed with a standard
semisynthetic germ-free rodent diet for 2 weeks, as described
previously, to allow establishment of the HBM (Martin et al, 2008).
The full trial design is given in Figure 1. A control group of HBM mice
(n¼10) received a saline drink containing Man, Rogosa and Sharpe
(MRS) culture medium and were fed with a basal diet containing 2.5%
of a glucose–lactose mix (1.25% each) for 2 additional weeks. Two
groups of HBM mice were given daily a probiotic supplement, either
L. paracasei (group A, n¼9) or L. rhamnosus (group D, n¼9), containing
108 probiotic bacteria in MRS per day mixed with saline solution and
were also fed with the basal diet. Two groups of HBM mice were fed
with a diet containing 3 g per 100 g diet of commercially available
galactosyl-oligosaccharide prebiotics (Vivinal-GOS, Borculo Domo
Ingredients, The Netherlands), called Pre1 here. Pre1 comprises 75%
dry matter in syrup and on a dry matter basis is composed of 23%
lactose, 22% glucose, 0.8% galactose and 57% galactosyl-oligosac-
charides with a degree of polymerization (DP) ranging between 3 and
9, and primarily composed of b-1,4 linkages. Amaretti et al (2007)
previously reported the relative sugar composition of Vivinal GOS.
DP 3 oligomer formed a major part of the oligosaccharides used and
accounted for 37% of total carbohydrates, whereas the concentration
of other oligomers decreased with the increase in DP (Amaretti et al,
2007). Two additional groups of HBM mice were fed with a diet
containing 3 g per 100 g diet of an in-house preparation of galacto-
oligosaccharides, called Pre2 here. Pre2 is composed of 80% of Pre1
and 20% of a mixture containing additional galactosyl-oligosaccharide
structures, the latter being primarily composed of DP 3 oligomers with
b-1,3 and b-1,6 linkages. The control diet was supplemented with
lactose and glucose to control for the lactose and glucose that were
added to the experimental diets by means of galactosyl-oligosacchar-
ide preparations. Additionally, all groups received daily a fresh
probiotic, either L. paracasei (group B, n¼9; group C, n¼9) or
L. rhamnosus (group E, n¼10; group F, n¼9). With an average
consumption of 5 ml of drinking water per mouse per day, each animal
received 108 CFU probiotics per day. Fecal pellets and morning spot
urine samples were collected and frozen for NMR spectroscopy at the
end of the 2 weeks of nutritional intervention. An additional fecal
pellet was also collected in sterile condition for microbial profiling.
Urine samples were not obtained for every animal, as some mice had
an empty bladder at the time of termination (i.e. total urine samples
per group was A, n¼6; B, n¼8; C, n¼6; D, n¼8; E, n¼6; F, n¼7).
Animals were weighed and then euthanized. Blood (400 ml) was
collected into Li-heparin tubes and the plasma was obtained after
centrifugation and then frozen at 801C. For jejunal microbiota
analysis, the first 8 cm of the jejunum was collected into sterile tubes
containing Ringer solution (Oxoid, UK), homogenized and kept on ice
before microbial profiling. The cecal content was collected in
Eppendorft tubes and a central section of the median lobe of the
liver was dissected. Samples were snap-frozen immediately and kept
at 801C before analysis.
Microbial profiling of fecal and jejunal contents
Briefly, for each mouse, a fecal pellet was homogenized in 0.5 ml
Ringer solution supplemented with 0.05% (w/v) L-cysteine (HCl). For
fecal and jejunal samples, solutions at different dilutions were plated
on selective and semiselective culture media to assess the bacterial
populations, B. breve and B. longum on Eugon Tomato medium
(Chemie Brunschwig, Switzerland), L. paracasei and L. rhamnosus on
MRS medium (Chemie Brunschwig) with antibiotics (phosphomycin,
sulfamethoxazole and trimethoprim) medium (Sigma, Switzerland),
C. perfringens on NN-agar medium (Chemie Brunschwig), E. coli on
Drigalski medium (Bio-Rad, Switzerland), Bacteroides distasonis on
Shaedler Neo Vanco medium (BioMe´rieux, Switzerland) and S. aureus
and S. epidermidis on Chapman medium (BioMe´rieux). The bacterial
cultures of E. coli, S. aureus and S. epidermidis were incubated at 371C
under aerobic conditions for 24 h and those of B. longum, B. breve,
L. rhamnosus, L. paracasei, Bacteroides distasonis and C. perfringens
under anaerobic conditions for 48 h.
Gas chromatographic analysis of cecal content
Cecal extracts were obtained from an aliquot from the cecum with 4 ml
buffer (0.1% (w/v) HgCl2 and 1% (v/v) H3PO4) containing 0.045 mg/
ml 2,2-dimethylbutyric acid (as an internal standard) per gram fresh
weight. The resulting slurry was centrifuged for 30 min at 5000 g at 41C
and the supernatant containing SCFAs was analyzed using a gas
chromatograph (HP 6890) equipped with flame ionization detector
and a DB-FFAP column (J&W Scientific, MSP Friedli & Co., Switzer-
land) of 30 m length, 530mm diameter and 1 mm film thickness. The
system was run with helium gas at an inlet constant pressure of 10 psi
at 1801C. A cleaning injection of 1.2% formic acid was used before
each analysis. Samples were run at an initial temperature of 801C for
1.2 min followed by heating to 1451C in 6.5 min, heating to 2001C in
0.55 min and an additional 0.5 min at 2001C. SCFAs were identified and
quantified using the internal standard as well as external standards
consisting of acetate, propionate, isobutyrate, n-butyrate, isovalerate
and n-valerate.
1H NMR spectroscopic analysis of biofluids
and extracts
Plasma samples (100ml) were introduced into a 5 mm NMR tube with
450ml of saline solution containing 10% D2O as the locking substance.
Urine samples were prepared by mixing 20 ml of samples with 30ml of a
phosphate buffer solution containing 90% D2O and 0.25 mM
3-trimethylsilyl-1-[2,2,3,3-2H4] propionate (TSP), which was used as
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a chemical shift reference, into 1.7 mm NMR tubes. Fecal pellets were
homogenized in 650 ml of a phosphate buffer solution containing 90%
D2O and 0.25 mM TSP. The homogenates were sonicated at ambient
temperature (298 K) for 30 min to destroy bacterial cells and then
centrifuged at 6000 g for 20 min. The supernatants were removed and
centrifuged again at 6000 g for 10 min. Aliquots of 550 ml were then
pipetted into 5 mm NMR tubes. Intact liver samples were bathed in an
ice-cold saline D2O solution. A portion of the tissue (B15 mg) was
packed into a zirconium oxide 4 mm outer-diameter rotor.
All 1H NMR spectra were recorded on a Bruker DRX 600 NMR
spectrometer (Bruker Biospin, Rheinstetten, Germany) operating at
600.11 MHz for 1H observation. 1H NMR spectra of plasma, urine and
fecal extracts were acquired with a Bruker 5 mm TXI triple-resonance
probe at 298 K. 1H NMR spectra of intact liver tissues were acquired
using a standard Bruker high-resolution MAS probe under magic-
angle-spinning conditions at a spin rate of 5000 Hz (Waters et al, 2000).
Tissue samples were regulated at 283 K using cold N2 gas to minimize
any time-dependent biochemical degradation.
1H NMR spectra of urine and fecal extracts were acquired using a
standard one-dimensional pulse sequence (D1-901-t1-901-tm-901-free
induction decay (FID)). NMR spectra of plasma and tissues were
acquired using the Carr-Purcell-Meiboom-Gill (CPMG, D1-901-(t-1801-t-)
n-FID) spin-echo pulse sequence with water suppression. Standard
spectra were acquired with a relaxation delay D1 of 2 s during which
the water resonance was selectively irradiated, and a fixed interval t1
of 3 ms. The water resonance was irradiated for a second time during
the mixing time tm of 100 ms. CPMG spin-echo spectra were registered
using a spin-echo loop time (2nt) of 160 ms for plasma and 200 ms for
tissue (Meiboom and Gill, 1958) and a relaxation delay of 2.5 s. A total
of 128 and 256 transients were collected into 32K data points for
standard and CPMG spectra respectively, with a spectral width of
20 ppm.
The FIDs were multiplied by an exponential weighting function
corresponding to a line broadening of 0.3 Hz. The acquired NMR
spectra were manually phase- and baseline-corrected using the
software package XwinNMR 3.5 (Bruker Biospin), and referenced to
the chemical shift of the methyl resonance of alanine at d 1.466 for
plasma and tissue spectra and that of TSP at d 0.00 for urine and fecal
extract samples.
For assignment purposes, 2D COrrelation SpectroscopY (COSY)
(Nagayama, 1980) and TOtal Correlation SpectroscopY (TOCSY) (Bax
and Davis, 1985) NMR spectra were acquired on selected samples using a
Bruker AV 400 spectrometer operating at 400.13MHz for 1H observation
equipped with a Bruker 5mm SEI (1H-13C) inverse probe with a z-axis
field gradient coil at 298K. Further assignment of the metabolite peaks
was also accomplished with the use of STOCSYon 1D spectra.
Multivariate statistical analysis and visualization
Statistical analysis of the changes in animal weights, bacterial
populations and in the cecal composition of SCFAs obtained by GC
was carried out using a two-tailed Mann–Whitney test.
The 1H NMR spectra were converted into 22K data points over the
range of d 0.2–10.0 using an in-house-developed MATLAB routine. The
regions containing the water resonance (d 4.5–5.19) and, for urine
spectra only, the urea resonance (d 4.5–6.2) were removed. The
spectra were normalized to a constant total sum before chemometric
analyses. The multivariate pattern recognition techniques used in this
study were based on the O-PLS-DA approach with unit-variance
scaling (Trygg and Wold, 2003). The O-PLS-DA loadings plots were
processed according to the method described by Cloarec et al (2005b).
Here, the test for the significance of Pearson product-moment
correlation coefficient was used to calculate the cutoff value of the
correlation coefficients at the level of Po0.05. To test the validity of the
model against overfitting, the cross-validation parameter Q2 was
computed and the standard seven-fold cross-validation method was
used (Cloarec et al, 2005b). Additional validation of the statistical
modeling on urine, liver, feces and bacterial counts was performed
using permutation testing based on cross-model validation methods
recently published by Westerhuis et al (2008). The means of the
distributions of the Q2 parameters obtained using random permuta-
tions are significantly different and lower than the experimental
Q2 parameters at 95% confidence interval using a one-tailed t-test.
These data provide compelling evidence of the statistical validity of the
models generated, and the results are provided as Supplementary
information (Supplementary Figures 4 and 5).
Pixel map representation of the inter-compartment
metabolic correlation
A statistical correlation analysis was applied to normalize the
intensities of spectral peaks found to be significantly different with
nutritional intervention to establish possible association between
metabolites across different biological compartments. Pearson’s
correlation coefficients were computed between influential metabolite
relative intensities derived from liver and fecal metabolic profiles from
the same mice within each group of mice colonized with one type of
probiotic. Pixel maps were used to display the correlation matrices,
and a cutoff value of 0.4 was applied to the absolute value of the
coefficient |r| so that the map represents only those correlations
between two metabolites that are above the cutoff. The value and the
sign of the correlation were then color-coded (gradient of red colors for
positive values, gradient of blue colors for negative values). The
presence of colored pixels between specific metabolites reveals a
correlation (above the cutoff) between these molecules that may
reflect a functional association.
Bipartite graph representation of connectivities
between SCFAs and microbial profiles
The bipartite graph (Rgraphsviz) package from R (Free Software
Foundation General Public License, USA, Version 2.5.1) was used to
display the correlation matrix derived from cecal SCFAs and microbial
profiles (jejunal and fecal) to assess the prebiotic-induced changes in
the microbial metabolism. Pearson’s correlation coefficients were
computed between cecal SCFAvariables and microbiota variables from
the same mice and a cutoff value of 0.5 was applied to the absolute
value of the coefficient |r| so that the bipartite graph represents only
those correlations between the two types of nodes (microbiota and
SCFAs) that are above the cutoff (Martin et al, 2007a). The sign of the
initial correlation was then color-coded (red positive, blue negative)
and the correlation value displayed on the bipartite graph. In that
context, presence of edges between two specific nodes (one of each
type) reveals a correlation (above the cutoff) between these entities
that may reflect a functional association.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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